SCHEMBL8153541

SCHEMBL8153541

O=C(O)c1cc2c([nH]1)CC=C2

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NFKB1 P19838 2/20 0.42
ALOX15 P16050 1/20 0.42
BLM P54132 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
ALDH1A1 P00352 3/20 0.38
LMNA P02545 2/20 0.38
CYP2C19 P33261 3/20 0.36
DAO P14920 6/20 0.35
KDM4E B2RXH2 3/20 0.35
HPGD P15428 3/20 0.35
HSD17B10 Q99714 3/20 0.35
GPR35 Q9HC97 3/20 0.35
MAPT P10636 1/20 0.35
SRD5A2 P31213 1/20 0.35
TSHR P16473 2/20 0.34
SMAD3 P84022 1/20 0.33
GRIN1 Q05586 2/20 0.33
F7 P08709 1/20 0.33
F3 P13726 1/20 0.33
PIN1 Q13526 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27868349 0.81 NFKB1 (0.39) NFKB1ALOX15BLMSMN1; SMN2ALDH1A1
SCHEMBL27936355 0.72 ALDH1A1 (0.38) NFKB1ALOX15BLMSMN1; SMN2ALDH1A1
SCHEMBL8151464 0.71 NFKB1 (0.43) NFKB1ALOX15BLMSMN1; SMN2ALDH1A1
SCHEMBL21983680 0.70 ALOX15 (0.36) NFKB1ALOX15BLMSMN1; SMN2ALDH1A1
SCHEMBL22495661 0.70 ALOX15 (0.36) NFKB1ALOX15BLMSMN1; SMN2ALDH1A1
SCHEMBL27528179 0.67 KDM4E (0.35) NFKB1ALOX15BLMSMN1; SMN2ALDH1A1
SCHEMBL1004852 0.64 ALDH1A1 (0.59) NFKB1ALOX15BLMSMN1; SMN2ALDH1A1
SCHEMBL1423043 0.64 ALDH1A1 (0.65) NFKB1ALOX15BLMSMN1; SMN2ALDH1A1
SCHEMBL8163967 0.63 ALDH1A1 (0.62) NFKB1ALOX15BLMSMN1; SMN2ALDH1A1
SCHEMBL8168410 0.63 ALDH1A1 (0.62) NFKB1ALOX15BLMSMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3500569-B1 2-OXO-IMIDAZOPYRIDINES AS REVERSIBLE BTK INHIBITORS AND USES THEREOF MERCK PATENT GMBH (DE) 2022-05-18 EP disclosed
CN-109641892-B 2-oxo-imidazopyridines as reversible BTK inhibitors and uses thereof 默克专利有限公司 2021-07-02 CN disclosed
US-7902252-B2 Inhibitors of D-amino acid oxidase SEPRACOR, INC. (US) 2011-03-08 US disclosed
US-7902252-B2 Inhibitors of D-amino acid oxidase SEPRACOR, INC. (US) 2011-03-08 US disclosed
WO-2011011330-A2 INHIBITORS OF D-AMINO ACID OXIDASE SEPRACOR INC. (US) 2011-01-27 WO disclosed
US-20100029737-A1 INHIBITORS OF D-AMINO ACID OXIDASE SEPRACOR INC. (US) 2010-02-04 US disclosed
US-20100029737-A1 INHIBITORS OF D-AMINO ACID OXIDASE SEPRACOR INC. (US) 2010-02-04 US disclosed
US-20090099248-A1 INHIBITORS OF D-AMINO ACID OXIDASE SEPRACOR INC. (US) 2009-04-16 US disclosed
US-20090099248-A1 INHIBITORS OF D-AMINO ACID OXIDASE SEPRACOR INC. (US) 2009-04-16 US disclosed
WO-2008089453-A2 INHIBITORS OF D-AMINO ACID OXIDASE SEPRACOR INC. (US) 2008-07-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090099248-A1 INHIBITORS OF D-AMINO ACID OXIDASE DDO, DAO, ACHE NFKB1 3351/4885ALOX15 98/4885BLM 4815/4885
US-20100029737-A1 INHIBITORS OF D-AMINO ACID OXIDASE DDO, DAO, ACHE NFKB1 3351/4885ALOX15 98/4885BLM 4815/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.